Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy.
about
Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous NephropathyEnigma (partially) resolved: phospholipase A2 receptor is the cause of "idiopathic" membranous glomerulonephritisTranslational nephrology: what translational research is and a bird's-eye view on translational research in nephrologyEpigenetic control of phospholipase A2 receptor expression in mammary cancer cellsPharmacological treatment of primary membranous nephropathy in 2016.Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy.Membranous Nephropathy: A Journey From Bench to BedsideClinical Features and Outcomes in Patients With Membranous Nephropathy and Crescent Formation.Phospholipase A2 Receptor Gene Polymorphisms Alter its Functions and Present a Genetic Risk of an Increased Intima-Media Thickness of the Carotid Artery.Biomarkers to detect membranous nephropathy in Chinese patients.Recent advances in the understanding of immune-mediated nephrotic syndrome: diagnostic and prognostic implications.Designing drugs that combat kidney damage.Intravenous cyclophosphamide and oral prednisolone is a safe and effective treatment option for idiopathic membranous nephropathy.Immunology of membranous nephropathy: from animal models to humans.Primary Membranous Nephropathy.Optimizing the translational value of animal models of glomerulonephritis: insights from recent murine prototypes.Membranous nephropathy in the kidney allograft.Blocking peptides and molecular mimicry as treatment for kidney disease.Membranous nephropathy-one morphologic pattern with different diseases.PLA2R and THSD7A: Disparate Paths to the Same Disease?Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy.Anti-Phospholipase A2 Receptor Autoantibody: A New Biomarker for Primary Membranous Nephropathy.The dominant humoral epitope in phospholipase A2 receptor-1: presentation matters when serving up a slice of π.Immune Response against Autoantigen PLA2R Is not Gambling: Implications for Pathophysiology, Prognosis, and Therapy.MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy.Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy.A New Classification System for IgG4 Autoantibodies.Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy.HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R-Related Membranous Nephropathy.The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous Nephropathy.Kidney disease models: tools to identify mechanisms and potential therapeutic targets.Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.PLA2R and membranous nephropathy: A 3 year prospective Australian study.Preparation of an epitope-based recombinant diagnostic antigen specific to anti-phospholipase A2 receptor 1 antibodies.Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.The prognostic value of phospholipase A2 receptor autoantibodies on spontaneous remission for patients with idiopathic membranous nephropathy: A meta-analysis.The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation.Human anti-thrombospondin type 1 domain-containing 7A antibodies induce membranous nephropathy through activation of lectin complement pathway.Identification of a two-SNP PLA2R1 Haplotype and HLA-DRB1 Alleles as Primary Risk Associations in Idiopathic Membranous Nephropathy
P2860
Q27023372-B90DF1A4-C49E-4038-AA93-CBE488A2F31BQ28083035-71942F1A-54A6-4869-8F6E-80021426E7F7Q35026517-1FE8855A-5357-4722-B02A-E4922F281237Q35870127-C74D6D06-C7CD-4168-8277-8554272C4DB1Q36106413-80120E9E-3398-474A-9EBA-802AEDD9892EQ36849177-17B730AF-B8D3-4D3B-8C98-54D69AB44021Q37038576-0E8F3F49-9F40-427D-BF54-2637B75E485DQ37328402-9ADB7B1D-C488-44A9-B975-258F41990E9DQ37398564-E20C1302-0A4D-47C8-988F-01F466F935C9Q37708722-B42C4F49-A054-4EED-9DCC-4286C037D931Q38371343-9B34D468-67FE-4B15-B805-60A418E8C935Q38404587-CE47C238-6BD6-4822-A0EE-E72781BA54DEQ38602846-33337B1B-9B89-420F-A54D-E24A3A6E2036Q38605469-B59ACF93-12C9-4AF7-A194-DF8567CA4501Q38760741-D2210FF6-FB5B-4E13-921D-DFE9D70C246BQ38874091-3358F7F5-E966-4C64-B51A-CBBBC414FFE8Q38959093-96D09A74-54B7-46C1-94FC-92A2EB36F9C3Q38961136-D43D8FD5-0CA9-4C14-A61B-98B36942B438Q39337229-9A80049B-F73A-4634-B8F1-025AF49A8A5BQ39412533-6DFFD9FC-171E-4F94-B4DD-F7F1D6265B7DQ41622450-2E1E2E6C-3CA7-4BA3-8842-E561FF83DC4AQ42286490-208E86DD-B9C1-4CA1-B4EB-8BA7AD44CF08Q42554767-00C95896-6C7C-42DE-84DE-A34B718FECDAQ42849501-599AB9F8-8BCA-4BFB-844F-709CE7946AECQ46459379-B0BDD08B-49B2-46DC-A640-D0809EB2165DQ50116914-9B4CA473-E802-472B-A8D1-9BBEFF982C45Q50327901-F097DA8C-AC28-4D09-8302-309F877BD9E9Q50908320-CF1F0667-68DD-4667-96AA-14AE70842BBEQ51232520-9805970A-1A48-4AD7-9C3D-C310EC0D89FCQ52349819-053C522D-4E4F-4D4B-AED2-342A9B39679CQ52668596-42DB9596-441D-4E0D-86BE-E0BBD57DC3B2Q52670774-225CB64E-E7F7-476F-B2FB-04EB7D4BC1DAQ53345487-F5C79ED4-0B3B-49D5-BFF9-376DDFE8250AQ55024771-FE9CC37A-288F-4BB7-85E5-7ACA4C13D4BFQ55243742-FAD4B373-830D-48B4-81D7-62886E32E66BQ55263929-4C8FFAC0-17C5-4644-B244-F1631EE0CD9CQ55483623-D64C093B-0E25-495A-8595-BF5E9F52E0D6Q55497142-7CF4F803-1593-4294-8456-0672DA60DCC1Q57805704-50263AAF-22F7-4834-AD45-41D30E658BAB
P2860
Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Identification of the immunodo ...... pathic membranous nephropathy.
@ast
Identification of the immunodo ...... pathic membranous nephropathy.
@en
type
label
Identification of the immunodo ...... pathic membranous nephropathy.
@ast
Identification of the immunodo ...... pathic membranous nephropathy.
@en
prefLabel
Identification of the immunodo ...... pathic membranous nephropathy.
@ast
Identification of the immunodo ...... pathic membranous nephropathy.
@en
P2093
P2860
P356
P1476
Identification of the immunodo ...... pathic membranous nephropathy.
@en
P2093
Meryl Waldman
Quansheng Zhu
Richard J Glassock
Vinson Lam
P2860
P304
P356
10.1681/ASN.2013121315
P577
2014-09-09T00:00:00Z